APA

Kanellopoulos A., Kaparou M., Xenou E., Paneesha S., Kishore B., Lovell R., Holder K., Suhr J., Baker L., Ryan L. & Nikolousis E. (20191001). Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia. : Bone marrow transplantation.

Chicago

Kanellopoulos A, Kaparou M, Xenou E, Paneesha S, Kishore B, Lovell R, Holder K, Suhr J, Baker L, Ryan L and Nikolousis E. 20191001. Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia. : Bone marrow transplantation.

Harvard

Kanellopoulos A., Kaparou M., Xenou E., Paneesha S., Kishore B., Lovell R., Holder K., Suhr J., Baker L., Ryan L. and Nikolousis E. (20191001). Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia. : Bone marrow transplantation.

MLA

Kanellopoulos A, Kaparou M, Xenou E, Paneesha S, Kishore B, Lovell R, Holder K, Suhr J, Baker L, Ryan L and Nikolousis E. Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia. : Bone marrow transplantation. 20191001.